Item 8.01 Other Events.

On December 6, 2022, EQ Health Acquisition Company (the "Company") filed a definitive proxy statement relating to a special meeting of shareholders to approve (i) an amendment (the "Charter Amendment") to the Company's amended and restated certificate of incorporation (the "Charter Amendment Proposal"), and (ii) an amendment to the Investment Management Trust Agreement, dated January 28, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (the "Trust Amendment Proposal" and together with the Charter Amendment Proposal, the "Proposals"), which would, if implemented, allow the Company to redeem all of its outstanding shares of Class A common stock, par value $0.0001 per share (the "Public Shares") in advance of the Company's contractual expiration date of February 2, 2023 by changing the date by which the Company must cease all operations except for the purpose of winding up if it fails to complete a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination (a "Business Combination") from February 2, 2023 to the later of (x) December 21, 2022 or (y) the date of effectiveness of the Charter Amendment (the "Amended Termination Date").

If the Proposals are approved, and because the Company will not be able to complete an initial Business Combination by the Amended Termination Date, the Company will be obligated to redeem all Public Shares as promptly as reasonably possible but not more than ten business days after the Amended Termination Date (the "Mandatory Redemption"). The Company expects to complete the Mandatory Redemption on or around December 28, 2022, if shareholders approve the Proposals. Additionally, the last day of trading of the Public Shares will be December 21, 2022, if shareholders approve the Proposals.

The virtual special meeting will be held on Tuesday, November 21, 2022 at 1:00 p.m. Eastern Time, and the record date for the meeting is the close of business (New York time) on December 1, 2022.





Forward-Looking Statements

This Current Report on Form 8-K includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Certain of these forward-looking statements can be identified by the use of words such as "believes," "expects," "intends," "plans," "estimates," "assumes," "may," "should," "will," "seeks," or other similar expressions. Such statements may include, but are not limited to, statements regarding the impact of the Company's restatement of certain historical financial statements, the Company's cash position and cash held in the Trust Account and any proposed remediation measures with respect to identified material weaknesses. These statements are based on current expectations on the date of this Current Report on Form 8-K and involve a number of risks and uncertainties that may cause actual results to differ significantly. The Company does not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.

© Edgar Online, source Glimpses